CRO Services - ACTG-CRO

bioéquivalence.jpg

Bioequivalence Studies

Regulatory Agencies require generic drug manufacturers to show that generic drugs are bioequivalent to the reference drug.

Bioequivalence studies can also be required for pharmaceutical variations made to drugs. 

At ACTG-CRO, we provide you a dedicated Bioequivalence Site Partner in Africa to run your studies under our supervision and management for a successful study.

Clinical Research, Tunisia, Africa, Clinical Trials, CRA, SCRA, Clinical Research Associate, GCP, Monitor, Monitoring, Senior Clinical Research Associate, CRA I, CRA II, CRA III, LCRA, Oncology, Cardiovascular, Neuroscience, Immunology, Infectious Diseases, Metabolism, Field Based, Home Based, CRO, Pharmaceutical